📰 Sergio Traversa News
Page 3 - Sergio Traversa News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sergio Traversa. Real-time updates on events, politics, business and more.
July 23, 2022
Relmada Therapeutics Appoints Biopharmaceutical Marketing and Commercial Planning Veteran John Hixon as Head of Commercial - read this article along with other careers information, tips and advice on BioSpace
July 21, 2022
/PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...
May 6, 2022
/PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...
March 23, 2022
/PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...
March 10, 2022
/PRNewswire/ -- Relmada Therapeutics, Inc. (NASDAQ: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...
December 22, 2021
/PRNewswire/ -- Relmada Therapeutics, Inc. (NASDAQ: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...
November 23, 2021
PALM BEACH, Fla., Nov. 23, 2021 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - The COVID-19 pandemic is expected to have a significant positive impact on the growth of the global antidepressant
November 23, 2021
/PRNewswire/ -- FinancialNewsMedia.com News Commentary - The COVID-19 pandemic is expected to have a significant positive impact on the growth of the global...
June 1, 2021
/PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...